Introduction: The DNA of a Biotech BoomThe global plasmid DNA manufacturing market is entering a transformative era, driven by revolutionary advancements in gene therapy, cancer immunotherapy, DNA ...

Prof. Si Longlong's team from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences constructed a ...

Vaccine-preventable diseases cost African countries a staggering USD 13 billion each year in direct and indirect expenses.

Fire is arguably humanity's earliest discovery. It was pivotal in advancing society—underpinning many of humanity's most ...

Dyadic International will present on its C1 platform at the 2025 World Vaccine Congress, focusing on avian influenza and preclinical research. Dyadic International, Inc., a biotechnology company ...

Scientists are testing and working on the world’s first acne vaccine, hoping to offer a long-term alternative to current ...

Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.

This necessitates large-scale vaccine production, a process that often presents significant challenges. Vaccine production employs a range of diverse and evolving technologies, from traditional ...

Acknowledging India’s contribution to TB vaccine research, Dr. Swaminathan noted that the overall TB vaccine pipeline remains ...

This new lipid nanoparticle production system developed by Shin-Etsu Chemical and Hokkaido University is capable of small-batch and mass production ...

Biopharmaceutical giant Merck (NYSE: MRK) has broken ground on a $1 billion pharmaceutical manufacturing facility in ...

IntroductionThe Global Plasmid DNA Manufacturing Market is poised for significant growth, with a valuation of USD 2.13 ...